norfloxacin has been researched along with probenecid in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (15.38) | 18.7374 |
1990's | 3 (23.08) | 18.2507 |
2000's | 2 (15.38) | 29.6817 |
2010's | 6 (46.15) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nezu, JI; Ohashi, R; Oku, A; Sai, Y; Shimane, M; Tamai, I; Tsuji, A; Yabuuchi, H | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Gozalbes, R; Pineda-Lucena, A | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Cao, CX; Neu, HC; Silverstein, SC; Steinberg, TH | 1 |
Dalton, H; Evans, T; Gruninger, RP; Kaplowitz, LG; Simpson, M; Vartivarian, S; Vishniavsky, N | 1 |
Irikura, T; Kusajima, H; Shimada, J; Uchida, H; Ueda, Y; Yamaji, T | 1 |
Jha, K; Roy, BK; Singh, RC | 1 |
Chenel, M; Comets, E; Couet, W; Forsell, A; Lamarche, I; Marchand, S | 1 |
1 review(s) available for norfloxacin and probenecid
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for norfloxacin and probenecid
Article | Year |
---|---|
Norfloxacin in the treatment of uncomplicated gonococcal infections.
Topics: Adult; Aged; Ampicillin; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Female; Gonorrhea; Humans; Male; Middle Aged; Norfloxacin; Probenecid; Random Allocation | 1987 |
11 other study(ies) available for norfloxacin and probenecid
Article | Year |
---|---|
Na(+)-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance.
Topics: Biological Transport, Active; Carnitine; Carrier Proteins; Cations; Cells, Cultured; Dose-Response Relationship, Drug; Embryo, Mammalian; Humans; Hydrogen-Ion Concentration; Kidney; Membrane Proteins; Organic Cation Transport Proteins; Sodium; Solute Carrier Family 22 Member 5; Stereoisomerism | 1999 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
QSAR-based solubility model for drug-like compounds.
Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
J774 macrophages secrete antibiotics via organic anion transporters.
Topics: Adenosine Triphosphate; Animals; Anti-Bacterial Agents; Carrier Proteins; Cell Line; Cell Membrane Permeability; Fluorescent Dyes; Isoquinolines; Macrophages; Mice; Norfloxacin; Penicillin G; Probenecid | 1992 |
Mechanism of renal excretion of AM-715, a new quinolonecarboxylic acid derivative, in rabbits, dogs, and humans.
Topics: Adult; Animals; Anti-Infective Agents; Creatinine; Dogs; Humans; Kidney; Male; Metabolic Clearance Rate; Nalidixic Acid; Norfloxacin; Probenecid; Rabbits; Species Specificity | 1983 |
The effect of induced fever on the biokinetics of norfloxacin and its interaction with probenecid in goats.
Topics: Analysis of Variance; Animals; Drug Interactions; Endotoxins; Escherichia coli; Female; Fever; Goats; Lipopolysaccharides; Metabolic Clearance Rate; Models, Biological; Norfloxacin; Probenecid | 1996 |
Norfloxacin blood-brain barrier transport in rats is not affected by probenecid coadministration.
Topics: Animals; Biological Transport; Blood-Brain Barrier; Brain; Drug Interactions; Male; Microdialysis; Norfloxacin; Probenecid; Rats; Rats, Sprague-Dawley | 2006 |